The recent approval of Novavax’s protein-based Covid-19 vaccine for adolescents aged 12-18 years will help its partner, the Serum Institute of India (SII) enter the adolescents’ market, according to GlobalData. Novavax’s Covid-19 vaccine was granted emergency use authorisation by the Drugs Controller General of India (DCGI) in March for adolescents aged 12-18 years. Novavax’s partner, […]